BioCryst Launches ORLADEYO® (berotralstat) in Italy
RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 -- BioCryst Pharmaceuticals, Inc. today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco , has finalized reimbursement and...
Source: marketscreener.com